67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas.

Tumor samples obtained from 72 patients resected for non-small cell lung cancer were stained immunohistochemically using an immunoperoxidase method and the MLuC5 monoclonal antibody specific for the 67-kDa laminin receptor. Sixty-one of 72 patients (84.7%) displayed a MLuC5-positive reaction, which was usually localized in both the inner surface of the plasmatic membranes and the cytoplasm of neoplastic cells. When we compared the laminin receptor expression with clinicopathological and biological parameters such as histotype, grading, T status, N status, ploidy, proliferative activity, vessel invasion, and p53 protein accumulation, the following results were observed: (a) the mean expression of the receptor was higher in the group of patients with metastatic nodal involvement than in those with uninvolved lymph nodes (P = 0.02); (b) a high Ki-67 score (>13% of positive cells) was observed in tumors with a higher mean value of laminin receptor (P = 0.004); (c) the tumors harboring neoplastic emboli in their vessels showed a higher laminin receptor immunoreactivity (P = 0.02); and (d) a borderline association was found between the high mean value of laminin receptor immunopositivity and p53 accumulation in neoplastic cell nuclei (P = 0.05). Our observations indicate that detection of high tissue levels of 67-kDa laminin receptor is associated with an invasive phenotype in non-small cell lung cancer and may provide further information in the biological characterization of this type of cancer.

[1]  C. Angeletti,et al.  p53 expression in non small cell lung cancer: clinical and biological correlations. , 1993, Anticancer research.

[2]  S. Ménard,et al.  Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. , 1993, Journal of the National Cancer Institute.

[3]  C. Angeletti,et al.  Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone. , 1992, The Journal of thoracic and cardiovascular surgery.

[4]  C. Angeletti,et al.  The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node‐negative non‐small cell lung cancer , 1992, Cancer.

[5]  D. Quinlan,et al.  Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. , 1992, Cancer research.

[6]  L. Liotta,et al.  Laminin receptors, collagenase IV and prognosis in node‐negative breast cancers , 1991, International journal of cancer.

[7]  S. Ménard,et al.  Laminin receptors on SCLC cells. , 1991, The British journal of cancer. Supplement.

[8]  L. Liotta,et al.  Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[9]  L. Liotta,et al.  Increased expression of the laminin receptor in human colon cancer. , 1991, Journal of the National Cancer Institute.

[10]  T. Ravikumar,et al.  Expression of a Mr 32,000 laminin-binding protein messenger RNA in human colon carcinoma correlates with disease progression. , 1990, Cancer research.

[11]  R. Tsuchiya,et al.  Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.

[12]  L. Liotta,et al.  Role of laminin receptor in tumor cell migration. , 1987, Cancer research.

[13]  C. Mountain,et al.  A new international staging system for lung cancer. , 1987, Chest.

[14]  D. Clayton,et al.  Tumour basement membrane laminin in adenocarcinoma of rectum: An immunohistochemical study of biological and clinical significance , 1986, International journal of cancer.

[15]  G. Laurie,et al.  Biological activities of laminin , 1985, Journal of cellular biochemistry.

[16]  G P Siegal,et al.  Loss of basement membrane components by invasive tumors but not by their benign counterparts. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[17]  L. Liotta,et al.  Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[18]  Rosen Pp.  Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance. , 1983 .

[19]  L. Liotta,et al.  Laminin receptor on human breast carcinoma cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Y. Shimosato,et al.  Histological Typing of Lung Tumours 1 , 1981 .